Clinical Trial Update: Excel Drug-Eluting Stent Pilot Clinical Registry [Phase 4]

View source ↗

Summary

Phase 4 clinical registry update for the Excel Drug-Eluting Stent in patients with coronary artery stenosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis

Drugs mentioned

• Excel Drug-Eluting Stent

Snippet

Sponsor: JW Medical Systems Ltd | Conditions: Coronary Stenosis | Phase 4 | Status: COMPLETED